Bengaluru: Newly married couple picked up by NIA on terror suspicion

Udupli, Jun 10: A promising Kabaddi player and young businessman allegedly committed suicide inside his father’s boat today at Malpe fishing port as he had suffered heavy loss in business due to covid lockdown. 

The deceased has been identified as Bhagyaraj (27), a resident of Pavanjigudde in Badanidiyoor, Bailakere. He was working as writer for two boats owned by his father. He was a well-known Kabaddi player in Udupi district. 

It is said that he had raised a huge loan to build a house and also acquired a fishing boat. However, he suffered heavy losses in business due to lockdown. Fish famine added to his woes. 

Upset by these developments, Bhagyaraj hanged himself inside his boat that was anchored at the port. A case was registered at Malpe police station. Investigations are on.

Mangaluru, May 4: An engineering student has claimed to have received 600 threat calls in the past few days from unidentified people for starting fish business during the lockdown in Kavoor. 

According to Sakshath Shetty, resident of Kavoor, he started receiving threat calls from various people after he started selling fish during the lockdown. 

Police said they have been able to identify some of the numbers from where the threat calls were made and investigation is under way.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.